Multi-Target Collaboration Agreement with Global Top 5 Pharma Company

Salipro has entered into a multi-target collaboration agreement with a global Top 5 pharmaceutical company in the USA.

This partnership leverages Salipro Biotech’s expertise and proprietary technology (Salipro®) to stabilise challenging drug targets including GPCRs, ion channels and transporters, making them accessible for the development of next-generation therapeutics.

Stay tuned for more updates as we continue to push the boundaries of drug discovery!